Explore All Access
Check if your research matches the topics covered in Hematology, Transfusion and Cell Therapy?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Hematology, Transfusion and Cell Therapy : Impact Factor & More
eISSN: 2531-1387pISSN: 2531-1379
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Hematology, Transfusion and Cell Therapy Key Metrics
CiteScore 
2
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months17%
4 to 6 months20%
7 to 9 months35%
Above 9 months28%
Did you find this useful?
Topics Covered on Hematology, Transfusion and Cell Therapy
Thalassemia
Hemophagocytic lymphohistiocytosis
Cold Agglutinin
Acute chest syndrome
Pediatric population
Intensive care unit
Vaso-occlusive crisis
Cold agglutinin disease
Hematology, Transfusion and Cell Therapy Journal Specifications
Indexed in the following public directories
Scopus 
DOAJ
| Overview | |
| Publisher | Elsevier |
| Language | English |
| Publication Time | 30 |
| Editorial Review Process | Double blind peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Sociedade Brasileira de Transplante de Medula Óssea (SBTMO), Associazione Italo-Brasiliana di Ematologia (AIBE), and Sociedade Brasileira de Oncologia Pediátrica (SOBOPE) |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors |
View less
Planning to publish in Hematology, Transfusion and Cell Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Hematology, Transfusion and Cell Therapy
Development and validation of the self-regulation of blood donation scale for blood donors
- 1 Nov 2024
- Hematology, Transfusion and Cell Therapy
Optical genome mapping identifies hidden structural variation in acute myeloid leukemia: Two case reports
- 1 Nov 2024
- Hematology, Transfusion and Cell Therapy
STAT5B::RARα-positive acute promyelocytic leukemia: Role of next generation sequencing in detection of a rare malignancy
- 1 Nov 2024
- Hematology, Transfusion and Cell Therapy
A NOVEL C.954G>T CHANGE (P.TRP318CYS) IN KLF1 GENE RESULTING IN AN IN(LU) PHENOTYPE
- 19 Oct 2024
- Hematology, Transfusion and Cell Therapy
THE NUMBER OF EXTRANODAL SITES IN NODAL PTCL: A PROPOSAL FOR A FEASIBLE PROGNOSTIC MARKER FOR OUTCOMES IN LOW-INCOME COUNTRIES. A COLLABORATIVE STUDY GRUPO DE ESTUDIO LATINO-AMERICANO DE LINFOPROLIFERATIVO (GELL) & T-CELL BRAZIL PROJECT (TCBP)
- 19 Oct 2024
- Hematology, Transfusion and Cell Therapy
LINFOMA DE ZONA MARGINAL ESPLÊNICA: O IMPACTO DE UM ADEQUADO EXAME FÍSICO NO DIAGNÓSTICO PRECOCE
- 1 Oct 2024
- Hematology, Transfusion and Cell Therapy
Development and validation of the self-regulation of blood donation scale for blood donors
- 1 Nov 2024
- Hematology, Transfusion and Cell Therapy
Optical genome mapping identifies hidden structural variation in acute myeloid leukemia: Two case reports
- 1 Nov 2024
- Hematology, Transfusion and Cell Therapy
STAT5B::RARα-positive acute promyelocytic leukemia: Role of next generation sequencing in detection of a rare malignancy
- 1 Nov 2024
- Hematology, Transfusion and Cell Therapy
A NOVEL C.954G>T CHANGE (P.TRP318CYS) IN KLF1 GENE RESULTING IN AN IN(LU) PHENOTYPE
- 19 Oct 2024
- Hematology, Transfusion and Cell Therapy
THE NUMBER OF EXTRANODAL SITES IN NODAL PTCL: A PROPOSAL FOR A FEASIBLE PROGNOSTIC MARKER FOR OUTCOMES IN LOW-INCOME COUNTRIES. A COLLABORATIVE STUDY GRUPO DE ESTUDIO LATINO-AMERICANO DE LINFOPROLIFERATIVO (GELL) & T-CELL BRAZIL PROJECT (TCBP)
- 19 Oct 2024
- Hematology, Transfusion and Cell Therapy
LINFOMA DE ZONA MARGINAL ESPLÊNICA: O IMPACTO DE UM ADEQUADO EXAME FÍSICO NO DIAGNÓSTICO PRECOCE
- 1 Oct 2024
- Hematology, Transfusion and Cell Therapy
Compare Similar Journals with Hematology, Transfusion and Cell Therapy
Select Journals to Compare with Hematology, Transfusion and Cell Therapy
Total journals - 8
You can select up to 3 Journals at a time
Blood
Publisher: AMER SOC HEMATOLOGY
Pediatric Blood and Cancer
Publisher: WILEY
Transfusion and Apheresis Science
Publisher: PERGAMON-ELSEVIER SCIENCE LTD
Journal of Pediatric Hematology/Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Journal of Blood Medicine
Publisher: DOVE MEDICAL PRESS LTD
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
American Journal of Hematology
Publisher: WILEY
International Journal of Infectious Diseases
Publisher: ELSEVIER SCI LTD
0 Journals Selected to compare with
Hematology, Transfusion and Cell Therapy
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Hematology, Transfusion and Cell Therapy
How many articles did Hematology, Transfusion and Cell Therapy publish last year? 
In 2023, Hematology, Transfusion and Cell Therapy publsihed 1922 articles.
What is the eISSN & pISSN for Hematology, Transfusion and Cell Therapy?
For Hematology, Transfusion and Cell Therapy, eISSN is 2531-1387 and pISSN is 2531-1379.
What is Citescore for Hematology, Transfusion and Cell Therapy?
Citescore for Hematology, Transfusion and Cell Therapy is 2.
Who is the publisher of Hematology, Transfusion and Cell Therapy?
Elsevier is the publisher of Hematology, Transfusion and Cell Therapy.
